Efficacy and Safety of TV-1380 for Facilitation of Abstinence in Cocaine-Dependent Subjects

Study Title

Efficacy and Safety of TV-1380 as Treatment for Facilitation of Abstinence in Cocaine-Dependent Subjects

Teva Identifier

TV1380-COA-201

ClinicalTrials.gov Identifier

NCT01887366

Study Status

Completed

Trial Condition(s)

Cocaine Addiction

Interventions

Drug: TV-1380 150 mg | Drug: TV-1380 300 mg | Drug: Placebo

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
ClinicalTrials.gov study records with inclusion and exclusion criteria
disease icon for clinical trials

Key Participation Requirements

Gender

Female, Male

Age Range

18 Years to 60 Years

Trial Duration

06/01/2013 - 10/01/2014

Phase

Phase 2

Study Type

Interventional